相关实验视频

Updated: May 20, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

对未知意义的APP,PSEN1和PSEN2变体进行AlphaMissense病原性预测的基准测试

Joshua Pillai^1,2, Sophia Liu³, Kijung Sung²

¹School of Biological Sciences, University of California, 9301 S Scholars Dr, La Jolla, San Diego, CA, 92093, USA.

Biochemistry and biophysics reports

|June 9, 2025

概括

AlphaMissense (AM) 准确地预测了阿尔茨海默病变体的致病性,超过了其他模型. 这种新的工具有助于对遗传突变进行分类,以更好地了解疾病和发现治疗方法.

科学领域:

遗传学遗传学是一个
神经科学是一个神经科学.
计算生物学计算生物学

背景情况:

阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,与APP,PSEN1和PSEN2等基因的突变有关.
将这些基因中的错误变异的致病性分类为了解AD机制和开发治疗方法至关重要.
许多未知意义的变体 (VUS) 需要对其分子后果进行准确的计算预测.

研究的目的:

评估AlphaMissense (AM) 的性能,这是一个新的计算工具,用于预测AD相关基因中错误感变异的致病性.
将AM与使用体外Aβ异型水平的既定致病性预测模型进行基准比较.
评估AM在PSEN1,APP和PSEN2中对VUS进行分类的能力.

主要方法:

使用AlphaMissense (AM) 来预测PSEN1,APP和PSEN2中的114个VUS的病原性得分.
预测与Aβ42/Aβ40比率和Aβ40水平的体外测量进行了比较.
用ROC-AUC分析对263个验证的变体和114个VUS进行了对比,将AM性能与CADD,EVE和ESM-1B进行了比较.

主要成果:

抗胰岛素得分与Aβ42/Aβ40和Aβ40水平有中度的相关性,表现优于CADD,EVE和ESM-1B.
在经过验证的变种上,AM表现出很高的表现,并在114个VUS的分类中表现出色.
即使在具有低AlphaFold2pLDDT分数的残留物上,AM也准确地预测了变异效应,表明结构背景之外的稳定性.

结论:

AlphaMissense是一种高效的工具,用于预测阿尔茨海默病相关基因中的错误感变异的致病性.
与现有的VUS分类模型相比,AM提供了更高的准确性,有助于AD研究和治疗开发.
这项研究提供了对AD相关遗传变异的第一个全面的AM验证.

关键词:

阿尔法Missense的意思是错误的意思阿尔茨海默氏症的疾病是阿尔茨海默氏症.在PSEN1上.在PSEN2中,我们可以使用PSEN2.病原性预测的预测.

更多相关视频

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...